Bringing together real-time monitoring, telemedicine, AI, interventions, and pharmaceuticals into a single device produces a number of potential pitfalls.
Mark Goodman and Barry Thompson, Baker & McKenzie LLP03.04.20
In 2019, I had to take a long, hard look at both my businesses and my industry to find balance and a way forward through the ripple effects of big changes.
Dawn A. Lissy, President & Founder, Empirical01.29.20